Atlanta, GA, United States of America

Claude-Raymond René

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016-2019

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Claude-Raymond René: Innovator in Hydrogel Formulation

Introduction

Claude-Raymond René, an accomplished inventor based in Atlanta, GA, has made significant contributions to the field of biotechnology with a focus on treatments for mammary tissue disorders. With a total of three patents to his name, René's work has showcased his dedication to improving health outcomes through innovative solutions.

Latest Patents

Among his latest patents is a groundbreaking hydrogel formulation designed with mild adhesion properties. This invention aims to address treatments related to mammary tissue problems, particularly in reducing the incidence of mastitis. The formulation creates a physical barrier on a teat surface, within a teat canal, or in a teat cistern, providing a prophylactic treatment option for mammary disorders.

Career Highlights

René has honed his expertise throughout his career while working with leading companies in the industry. Notably, he has held positions at both Zoetis Services LLC and Biocure Limited, where he contributed to the development of innovative treatment methods.

Collaborations

Throughout his professional journey, Claude-Raymond René has collaborated with esteemed colleagues such as Bruktawit T Asfaw and Christopher A Zook. These collaborations have played a vital role in enhancing his research and refining his patents.

Conclusion

Claude-Raymond René's innovative spirit and commitment to advancing biotechnology have established him as a notable inventor in his field. His contributions, particularly in hydrogel formulations for mammary tissue treatment, continue to pave the way for improved health solutions. As he builds on his achievements, the impact of his work will resonate within the healthcare community for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…